Previous 10 | Next 10 |
IRVINE, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced the launch of two new purpose-built products, the R...
IRVINE, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2022 Ethos and Sustain...
IRVINE, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced planned enrollment of the PEERLESS II trial, Inari...
2023-05-10 13:00:44 ET Summary Inari Medical, Inc. has several devices for venous thrombectomy like The FlowTriever and ClotTriever devices. Several ongoing clinical trials and increasing quarterly sales have the potential to continue the upside momentum for the stock price. I...
2023-05-09 13:25:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During the first quarter, Baron Discovery Fund® (the Fund) was up 11.20% compared...
2023-05-03 21:17:05 ET Inari Medical, Inc. (NARI) Q1 2023 Earnings Conference Call May 03, 2023, 04:30 PM ET Company Participants Caroline Corner - IR Drew Hykes - President and CEO Mitch Hill - CFO Tom Tu - Chief Medical Officer Conference Call Partici...
2023-05-03 17:01:19 ET Inari Medical press release ( NASDAQ: NARI ): Q1 GAAP EPS of -$0.04 beats by $0.19 . Revenue of $116.2M (+33.9% Y/Y) beats by $5.9M . Ended the quarter with $328.4 million in cash, cash equivalents and short-term investments. Outloo...
IRVINE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its first quarter ended ...
IRVINE, Calif., May 02, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that its management team will present a...
IRVINE, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2023...
News, Short Squeeze, Breakout and More Instantly...
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its second quarter 2024...
SAN FRANCISCO, June 27, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses now . Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit...
Hagens Berman Encourages NARI Investors with Substantial Losses to Contact Firm Before July 12, 2024 Deadline San Francisco, California--(Newsfile Corp. - June 26, 2024) - Hagens Berman urges Inari Medical, Inc. (NASDAQ: NARI) investors who suffered substantial losses to submit your losses no...